ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "work"

  • Abstract Number: 1077 • ACR Convergence 2021

    Effectiveness of Non-Pharmacological Interventions to Promote Work Participation of People with Rheumatic and Musculoskeletal Diseases: A Systematic Review and Meta-Regression Analysis

    Maarten Butink1, Casper Webers2, Suzanne Verstappen3, Robin Christensen4, Louise Falzon5, Johannes Bijlsma6, Gerd Burmester7 and Annelies Boonen2, 1Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+ (MUMC+); Department of Social Medicine, Care and Public Health Research Institute (CAPHRI), Maastricht, Limburg, Netherlands, 2Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+ (MUMC+), Maastricht, Limburg, Netherlands, 3School of Social Sciences, The University of Manchester, Manchester, United Kingdom, 4Section for Biostatistics and Evidence-Based Research, the Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen & Research Unit of Rheumatology, Department of Clinical Research, University of Southern Denmark, Copenhagen, Denmark, 5Center for Personalized Health, Northwell Health, New York City, NY, 6Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 7Charité University Medicine Berlin, Berlin, Germany

    Background/Purpose: Despite improvements in the treatment of rheumatic and musculoskeletal diseases (RMDs), reduced work participation persists when compared to the general population. A Task Force…
  • Abstract Number: 1118 • ACR Convergence 2021

    The Association of Hand OA with Paid an Unpaid Work Impairment and Related Costs: The Hand Osteoarthritis in Secondary Care Cohort

    Sietse Terpstra1, Lotte van de Stadt1, Annelies Boonen2, Frits Rosendaal1 and Margreet Kloppenburg1, 1Leiden University Medical Center, Leiden, Netherlands, 2Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Centre+ (MUMC+), Maastricht, Limburg, Netherlands

    Background/Purpose: Rheumatic musculoskeletal diseases (RMDs) can cause impairment at paid and unpaid work and contributes to societal burden and costs. However, data on this topic…
  • Abstract Number: 1186 • ACR Convergence 2021

    The Kardashian Index of Rheumatology Program Directors: Comparing Scholarly Activity and Twitter Use of Rheumatology Fellowship Program Directors in the United States

    Aakanksha Khanna1, Keerthy Gopalakrishnan2, Dawid Czarny1, Brian Quigley1 and Alysia Kwiatkowski1, 1State University of New York at Buffalo, Buffalo, NY, 2S.R.M. Medical College Hospital and Research Center, Buffalo, NY

    Background/Purpose: Social media has changed the way we communicate and disseminate information. Program directors (PDs) can use social media to boost visibility for professional networking,…
  • Abstract Number: 1187 • ACR Convergence 2021

    Is Your Program Website Optimized for Recruitment? An Evaluation of Rheumatology Fellowship Program Websites

    Temitope Ajayi, Aakanksha Khanna, Brian Quigley and Alysia Kwiatkowski, State University of New York at Buffalo, Buffalo, NY

    Background/Purpose: A program’s website is a helpful source of information for a prospective applicant whose decision on where to apply is influenced by the data…
  • Abstract Number: 1792 • ACR Convergence 2021

    Participation in Psoriatic Arthritis (PART2) – a Cross-sectional Study of Work Impairment in Psoriatic Arthritis Patients in the Netherlands

    Tamara van Hal1, Michelle Mulder1, Mark Wenink2 and Johanna Vriezekolk1, 1Sint Maartenskliniek, Nijmegen, Netherlands, 2Sint Maartenskliniek, Malden, Netherlands

    Background/Purpose: Psoriatic arthritis (PsA) can lead to pain, disability and a loss of quality of life [Rosen, Rheumatology 2012]. PsA can also lead to impairments…
  • Abstract Number: 1826 • ACR Convergence 2021

    Reduced Burden on Paid and Household Work Productivity with Stringent Thresholds of Disease Control: Further Results from Long-Term Certolizumab Pegol Treatment in Patients with Psoriatic Arthritis

    William Tillett1, Laura Coates2, Sandeep Kiri3, Vanessa Taieb3 and Philip Mease4, 1Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 2Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, United Kingdom, 3UCB Pharma, Slough, United Kingdom, 4Swedish Medical Center/Providence St. Joseph Health and University of Washington, Seattle, WA

    Background/Purpose: Psoriatic arthritis (PsA) is associated with a reduction in workplace productivity,1 which may extend into household productivity.2 Certolizumab pegol (CZP) is a tumor necrosis…
  • Abstract Number: 1926 • ACR Convergence 2021

    Effectiveness of the Making It Work™ Program at Improving Absenteeism in Workers with Inflammatory Arthritis – Results of a Randomized Controlled Trial

    Andre Luquini1, Yufei Zheng2, Hui Xie2, Catherine L. Backman3, Pamela Rogers4, Alex Kwok4, Astrid Knight4, Monique Gignac5, Dianne Mosher6, Linda Li3, John Esdaile7, Carter Thorne8 and Diane Lacaille2, 1University of British Columbia / Arthritis Research Canada, Fort Saint John, BC, Canada, 2Arthritis Research Canada, Richmond, BC, Canada, 3University of British Columbia, Vancouver, BC, Canada, 4Arthritis Research Canada / UBC, Vancouver, BC, Canada, 5Institute for Work & Health, Toronto, ON, Canada, 6University of Calgary, Calgary, AB, Canada, 7Arthritis Research Canada, Vancouver, BC, Canada, 8Southlake Regional Health Centre, Newmarket, ON, Canada

    Background/Purpose: Despite advances in treatment, absenteeism remains a major problem for workers living with inflammatory arthritis (IA), leading to reduced income and quality of life.…
  • Abstract Number: 0227 • ACR Convergence 2021

    Work Participation Is Impaired Months Before Clinical Arthritis Is Apparent

    Cleo Rogier1, Pascal de Jong2, Annette H.M van der Helm-van Mil3 and Elise van Mulligen4, 1Erasmus MC, Rotterdam, 2Erasmus MC, Hendrik Ido Ambacht, Netherlands, 3Leiden University Medical Center, Leiden, Netherlands, 4Erasmus Medical Center, Rotterdam, Netherlands

    Background/Purpose: Work participation is still a major issue for patients with rheumatoid arthritis (RA) despite improved management and outcomes. Work loss can be divided into…
  • Abstract Number: 0360 • ACR Convergence 2021

    Factors Associated with Pain Intensity in Axial Spondyloarthritis. Results from the EuropeanMap of Axial Spondyloarthritis (EMAS)

    Marco Garrido-Cumbrera1, Victoria Navarro-Compán2, Christine Bundy3, Laura Christen4, Raj Mahapatra5, Souzi Makri6, Carlos Jesús Delgado-Domínguez7, José Correa-Fernández7, Pedro Plazuelo-Ramos8 and Denis Poddubnyy9, 1Health & Territory Research (HTR), University of Seville, Sevilla, Spain, 2Rheumatology service, Hospital Universitario La Paz-IdiPaz, Madrid, Spain, 3Cardiff University, Cardiff, Wales, United Kingdom, 4Novartis Pharma AG, Basel, Switzerland, 5Axial Spondyloarthritis International Federation (ASIF), London, United Kingdom, 6Cyprus League Against Rheumatism (CYPLAR), Limassol, Cyprus, 7Health & Territory Research (HTR), Universidad de Sevilla, Seville, Spain, 8Spanish Federation of Spondyloarthritis Associations (CEADE), Madrid, Spain, 9Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany

    Background/Purpose: Pain is a hallmark of axial spondyloarthritis (axSpA) and can significantly deteriorate patients’ health status. This analysis aims to investigate factors associated with pain…
  • Abstract Number: 0366 • ACR Convergence 2021

    Why Is It so Difficult for AxSpA Patients to Find a Job? Results from the European Map of Axial Spondyloarthritis (EMAS)

    Marco Garrido-Cumbrera1, Victoria Navarro-Compán2, Christine Bundy3, Souzi Makri4, Laura Christen5, José Correa-Fernández6, Sergio Sanz-Gomez6, Raj Mahapatra7, Carlos Jesús Delgado-Domínguez6 and Denis Poddubnyy8, 1Health & Territory Research (HTR), University of Seville, Sevilla, Spain, 2Rheumatology service, Hospital Universitario La Paz-IdiPaz, Madrid, Spain, 3Cardiff University, Cardiff, Wales, United Kingdom, 4Cyprus League Against Rheumatism (CYPLAR), Limassol, Cyprus, 5Novartis Pharma AG, Basel, Switzerland, 6Health & Territory Research (HTR), Universidad de Sevilla, Seville, Spain, 7Axial Spondyloarthritis International Federation (ASIF), London, United Kingdom, 8Department of Rheumatology, Charité – Universitätsmedizin, Berlin, Germany

    Background/Purpose: AxSpA is associated with substantial negative consequences regarding work status and career prospects. The aim is to identify factors associated with barriers to job…
  • Abstract Number: 0810 • ACR Convergence 2021

    Persistent Disease Activity Impairs Work Productivity and Non-work Activity in Recent Onset Rheumatoid Arthritis

    Carol Hitchon1, Marie-France Valois2, Orit Schieir3, Susan Bartlett2, Louis Bessette4, Gilles Boire5, Glen Hazlewood6, Edward Keystone7, Janet Pope8, Carter Thorne9, Diane Tin10, Vivian Bykerk11 and Canadian Early Arthritis Cohort (CATCH) Investigators12, 1University of Manitoba, Winnipeg, MB, Canada, 2McGill University, Montréal, QC, Canada, 3Canadian Early Arthritis Cohort Study, Montréal, QC, Canada, 4Centre de l'Ostoporose et de Rhumatologie de Qubec, Québec City, QC, Canada, 5Universite de Sherbrooke, Sherbrooke, QC, Canada, 6University of Calgary, Calgary, AB, Canada, 7Keystone Consulting Enterprises Inc., Toronto, ON, Canada, 8University of Western Ontario, London, ON, Canada, 9Southlake Regional Health Centre, Newmarket, ON, Canada, 10The Arthritis Program Research Group, Newmarket, ON, Canada, 11Hospital for Special Surgery, New York, NY, 12Canadian Early Arthritis Cohort, Toronto, ON, Canada

    Background/Purpose: Reduced work and activity productivity are significant contributors to the personal and societal costs associated with rheumatoid arthritis (RA). We sought to describe work…
  • Abstract Number: 0141 • ACR Convergence 2020

    Filgotinib Improved Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate: Results from FINCH-1 Study

    Zobair Younossi1, Maria Stepanova2, Lynn Gerber1, Susan Lee3, Hao Hu3, Thijs Hendrikx4, Annelies Boonen5, David Walker6, Rieke Alten7 and Bernard Combe8, 1Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, 2Center for Outcomes Research in Liver Disease, Washington, DC, 3Gilead Sciences, Inc., Foster City, CA, 4Galapagos BV, Leiden, Netherlands, 5Maastricht University Medical Center, Maastricht, Netherlands, 6Northumbria Healthcare Trust, North Shields, United Kingdom, 7Schlosspark-Klinik, Universitätsmedizin, Berlin, Germany, 8University of Montpellier, Montpellier, France

    Background/Purpose: Filgotinib (FIL) is a potent oral selective janus kinase 1 inhibitor which is currently being investigated as an agent to treat rheumatoid arthritis (RA).…
  • Abstract Number: 0142 • ACR Convergence 2020

    Filgotinib Improved Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis and Inadequate Response to Biologic DMARDs: Results from the FINCH 2 Study

    Zobair Younossi1, Maria Stepanova2, Lynn Gerber1, Susan Lee3, I-Heng Lee4, Thijs Hendrikx5, Annelies Boonen6, Rieke Alten7, Bernard Combe8 and David Walker9, 1Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, 2Center for Outcomes Research in Liver Disease, Washington, DC, 3Gilead Sciences, Inc., Foster City, CA, 4Gilead Sciences, Foster City, CA, 5Galapagos BV, Leiden, Netherlands, 6Maastricht University Medical Center, Maastricht, Netherlands, 7Schlosspark-Klinik, Universitätsmedizin, Berlin, Germany, 8University of Montpellier, Montpellier, France, 9Northumbria Healthcare Trust, North Shields, United Kingdom

    Background/Purpose: Filgotinib (FIL) is a potent oral selective janus kinase 1 inhibitor which is currently being investigated as an agent to treat rheumatoid arthritis (RA).…
  • Abstract Number: 0143 • ACR Convergence 2020

    Filgotinib Improved Work Productivity and Activity Impairment in Patients with Rheumatoid Arthritis Who Are Methotrexate-naïve: Results from the FINCH-3 Study

    Zobair Younossi1, Maria Stepanova2, Lynn Gerber1, Susan Lee3, Ken Hasegawa3, Thijs Hendrikx4, Annelies Boonen5, Bernard Combe6, David Walker7 and Rieke Alten8, 1Betty and Guy Beatty Center for Integrated Research, Inova Health System, Falls Church, VA, 2Center for Outcomes Research in Liver Disease, Washington, DC, 3Gilead Sciences, Inc., Foster City, CA, 4Galapagos BV, Leiden, Netherlands, 5Maastricht University Medical Center, Maastricht, Netherlands, 6University of Montpellier, Montpellier, France, 7Northumbria Healthcare Trust, North Shields, United Kingdom, 8Schlosspark-Klinik, Universitätsmedizin, Berlin, Germany

    Background/Purpose: Filgotinib (FIL) is a potent oral selective janus kinase 1 inhibitor currently being investigated as an agent to treat rheumatoid arthritis (RA). In the…
  • Abstract Number: 0165 • ACR Convergence 2020

    Work Disability and Predictors of Poor Work Outcome in Patients with Axial Spondyloarthritis

    Elif Ediboglu1, Dilek Solmaz2, Hande Ece Oz3, Gokhan Kabadayı4, Haluk Cinaklı4, Eda Otman Akat3, Mustafa Ozmen4 and Servet Akar3, 1Izmir Katip Celebi University, Izmir, Izmir, Turkey, 2Izmir Katip Celebi University, Department of Internal Medicine, Division of Rheumatology, Izmir, TURKEY, Izmir, Turkey, 3Izmir Katip Celebi University, Izmir, Turkey, 4Izmir Katip Celebi University, Izmir

    Background/Purpose: Axial spondyloarthritis (axSpA) is a chronic inflammatory disease which may lead substantial functional limitation. The disease more commonly affects men in their third decade…
  • 1
  • 2
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2022 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies